Shortages of generic drugs should begin to ease in the coming weeks, according to a spokesperson for Canada's generic pharmaceutical industry. "Our members advise us that improvements to the situation can be expected over the next few weeks," Jeff Con-nell, director of public affairs for the Canadian Generic Pharmaceutical Association (CGPA), told CPJ in late September. "A number of companies say production of certain products is coming back online or being expanded." As an example, Mr. Connell points to a recent statement from leading generic drug manufacturer Teva Canada (formerly Novopharm), in which the company reports it has increased resources, and invested in new systems and equipment to overcome some of the shortage challenges. Action includes an expansion of its solid-dose production facility in Stouffville, Ontario.
展开▼
